Lung Diseases, Obstructive: all 2,585 studies

Page 24 of 26. Open to participants first (194), then studies with results posted, then the rest; newest registration first within each.

• A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic SubjectsWithdrawnNCT00830427Phase 2
• Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)CompletedNCT00826683Phase 3
• Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) SubjectsWithdrawnNCT00826566Not applicable
• Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00826163Phase 3
• A Registry of COPD Patients to be Used for Future StudiesCompletedNCT00814203
• A Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00808288Phase 2
• Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00807534Not applicable
• Responses Induced by Smoking in Individuals Being Susceptible and Non-Susceptible for Development of COPDStatus unknownNCT00807469
• Trial Comparing Effect of He/O2 to Medical Air on Pulmonary Function DiseaseCompletedNCT00801307Phase 1/2
• NOWOX Oxygen Therapy Monitoring DeviceCompletedNCT00800072Not applicable
• Correlation of Airflow Limitation and Other Respiratory Characteristics With Radiologic Changes of Lung StructureStatus unknownNCT00799305
• End-of-Life Fear in Patients With End-Stage Lung Disease (COPD)Status unknownNCT00792974
• Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical VentilationCompletedNCT00791505Phase 3
• Evaluation of Remote Patient Monitoring.WithdrawnNCT00789100
• The Use of a Forecasting System for Predicting Exacerbations of COPDCompletedNCT00788645Early Phase 1
• COPD and Cardiovascular Risk in the PopulationCompletedNCT00787748
• Validation of PROMIS Banks With COPD ExacerbationsCompletedNCT00784342
• Investigating the Impact of Mode of Administration on Item ResponseCompletedNCT00783991
• Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT00783250Phase 4
• Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
• Safety and Efficacy Study of Treatment With Single Doses of CHF 4226 pMDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00782535Phase 2
• Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy VolunteersCompletedNCT00777595Phase 1
• A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00774761Phase 2
• Pennsylvania Study Of Chronic Obstructive Pulmonary ExacerbationsCompletedNCT00774176
• A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00752414Phase 1
• Beta-Blocker in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT00745043Not applicable
• Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) PatientsTerminatedNCT00744614
• A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00744484Not applicable
• Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00742248Phase 2
• The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) PatientsStatus unknownNCT00741832Not applicable
• The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPDWithdrawnNCT00741767Not applicable
• Coping Skills for Patients With Chronic Obstructive Pulmonary Disease (COPD) and Their CaregiversCompletedNCT00736268Not applicable
• Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00734266
• EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous EmphysemaStatus unknownNCT00730301Phase 4
• Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.CompletedNCT00725673
• European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00722267
• Pilot Randomized Controlled Trial of a Breathlessness Intervention Service for Chronic Obstructive Pulmonary DiseaseCompletedNCT00711438Phase 2
• Non-invasive Ventilation in Severe Chronic Obstructive Pulmonary Disease(COPD)TerminatedNCT00710541Not applicable
• Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble BreathingCompletedNCT00707811
• Glasgow Supported Self Management Trial (GSuST)Status unknownNCT00706303Not applicable
• Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and CostsCompletedNCT00705302Not applicable
• Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00702156Phase 2
• Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00700921Phase 2
• The Prevalence of Gastro-oesophageal Reflux in Chronic Lung DiseaseCompletedNCT00697177
• A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00691405Phase 2
• Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisTerminatedNCT00690885Phase 2
• Improving Clinician Communication Skills (ICCS)CompletedNCT00687349Phase 3
• A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00685841Phase 3
• Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00685529Phase 2
• Simvastatin in Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00680641Phase 4
• Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary DiseaseCompletedNCT00672802Phase 2
• LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart FailureStatus unknownNCT00668408Phase 4
• Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00666367Phase 4
• Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00665600Phase 3
• Functional Tests in Individuals With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00660738
• Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPDCompletedNCT00648245Phase 2
• A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00642148Phase 2
• Confirmatory Dose Finding Study of 2 Dosages of CHF 4226 pMDI (Carmoterol) in Patients With COPDCompletedNCT00640484Phase 2
• Effectiveness and Safety of Inhaling Hypertonic Saline in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00639236Phase 4
• Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPDCompletedNCT00634413Phase 2
• Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)WithdrawnNCT00633776Phase 4
• Early Rehabilitation of COPD Patients in ICUTerminatedNCT00628992Not applicable
• Smoking Cessation in Patients With COPD (SMOCC) in General PracticeCompletedNCT00628225Phase 4
• Evaluation of Programs of Coordinated Care and Disease ManagementStatus unknownNCT00627029Not applicable
• Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCTCompletedNCT00624754Phase 2
• A Structured Lifestyle Intervention on Daily Physical Activity Level in COPDCompletedNCT00614796Not applicable
• Symbicort in Chronic Obstructive Pulmonary DiseaseCompletedNCT00611520
• Dose Finding Study of CHF 4226 for Treating Patients With COPDCompletedNCT00605891Phase 2
• Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPDCompletedNCT00583986Phase 3
• Study of Erythropoietin to Treat Anemia Complicating Chronic Obstructive Pulmonary DiseaseWithdrawnNCT00579046Phase 3
• Effect of Pressure Support Ventilation and Neurally Adjusted Ventilatory Assist (NAVA) in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00568100Not applicable
• Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy SmokersCompletedNCT00565214Not applicable
• Role of Natriuretic Peptides in the Treatment of Acutely Decompensated Heart Failure Patient With Obstructive Airways DiseaseTerminatedNCT00562692Phase 3
• Change of Inspiratory Peak Flow in COPDCompletedNCT00561886Phase 4
• Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00561223Not applicable
• A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00559910Phase 2
• Chronic Obstructive Pulmonary Disease (COPD) Outpatient on Demand ClinicCompletedNCT00556816Not applicable
• Systemic Endothelial Abnormalities in COPDWithdrawnNCT00555529
• Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities OnlyCompletedNCT00546299Not applicable
• Cognitive Behavioral Therapy for Anxiety and Depression in COPDCompletedNCT00545922Phase 2
• Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00545311Phase 1
• The Effects of a Home Exercise Video Programme for Patients With COPDCompletedNCT00542932Phase 2
• Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and AsthmaCompletedNCT00542282
• Monitoring Asthma and COPD in Primary CareCompletedNCT00542061Not applicable
• Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced DyspnoeaCompletedNCT00540163
• Effect of Steroids on Gene Expression in the Healthy Smokers LungsWithdrawnNCT00532584Phase 4
• Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00532350Phase 1
• Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute ExacerbationCompletedNCT00531791Phase 3
• Effects of Salmeterol on Walking Capacity in Patients With COPDCompletedNCT00525564Phase 4
• Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyCompletedNCT00517998Phase 1
• A Study to Examine the Effect of Particle Size on Bioequivalence and BioavailabilityCompletedNCT00517543Phase 1
• Noninvasive Positive Pressure Ventilation Using Helium:Oxygen Versus Air:Oxygen in Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease Patients Exposed to Sulfur MustardCompletedNCT00515606Phase 3
• US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyCompletedNCT00515164Phase 2
• Measurement of Soluble Factors and Particulate Matter in Induced Sputum and EBC in Inflammatory Diseases of the LungCompletedNCT00511290
• Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of WeightCompletedNCT00507949Phase 2
• Study in Subjects Greater Than 40 Years of Age With COPDCompletedNCT00507234Phase 3
• Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary HypertensionWithdrawnNCT00506701Not applicable
• Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung DiseaseCompletedNCT00504738
• Magnesium Loading in Chronic Obstructive Pulmonary DiseaseCompletedNCT00500864Phase 1/2
• Effects of Singing in Chronic Obstructive Pulmonary DiseaseCompletedNCT00500526Phase 1/2

← Lung Diseases, Obstructive overview